Cargando…
Advances of cancer-associated fibroblasts in liver cancer
Liver cancer is one of the most common malignant tumors worldwide, it is ranked sixth in incidence and fourth in mortality. According to the distinct origin of malignant tumor cells, liver cancer is mainly divided into hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). Since most cases are...
Autores principales: | Peng, Hao, Zhu, Erwei, Zhang, Yewei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380339/ https://www.ncbi.nlm.nih.gov/pubmed/35971182 http://dx.doi.org/10.1186/s40364-022-00406-z |
Ejemplares similares
-
Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers
por: Kaps, Leonard, et al.
Publicado: (2020) -
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
por: Zhang, Hao, et al.
Publicado: (2023) -
The origins, roles and therapies of cancer associated fibroblast in liver cancer
por: Zulaziz, Natasha, et al.
Publicado: (2023) -
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives
por: Fang, Zengli, et al.
Publicado: (2022) -
RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma
por: Peng, Hao, et al.
Publicado: (2022)